FibroBiologics Engages Southern Star Research as CRO in Australia
19. September 2024 09:31 ET
|
Fibrobiologics, Inc.
HOUSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the...
FibroBiologics Announces Filing of Patent Application for Generation of Functional Hematopoietic Organoids using Fibroblast Cell-Based Technology
12. September 2024 09:31 ET
|
Fibrobiologics, Inc.
HOUSTON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the...
FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
06. September 2024 09:31 ET
|
Fibrobiologics, Inc.
HOUSTON, Sept. 06, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the...
FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
20. August 2024 09:31 ET
|
Fibrobiologics, Inc.
HOUSTON, Aug. 20, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the...
FibroBiologics Files 2024 Second Quarter Report
07. August 2024 18:52 ET
|
Fibrobiologics, Inc.
HOUSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending for the development of...
FibroBiologics to Present at JonesTrading Healthcare Summit 2024
15. Juli 2024 09:31 ET
|
Fibrobiologics, Inc.
HOUSTON, July 15, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the...
FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
25. Juni 2024 09:31 ET
|
Fibrobiologics, Inc.
HOUSTON, June 25, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the...
FibroBiologics Set to Join Russell 2000® Index
13. Juni 2024 09:31 ET
|
Fibrobiologics, Inc.
HOUSTON, June 13, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the...
FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
06. Juni 2024 09:31 ET
|
Fibrobiologics, Inc.
HOUSTON, June 06, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the...
FibroBiologics Announces 2024 Annual Meeting of Stockholders
15. Mai 2024 16:30 ET
|
Fibrobiologics, Inc.
HOUSTON, May 15, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the...